Skip to main navigation
Go to Upstream Bio homepage Upstream Bio, Targeting Inflammation at Its Source for Better Health
  • About
  • Team
    • Leadership
    • Board
    • Advisors
  • Science
  • Join Us
  • Investors
    • News & Events
      • News Releases
      • Events
      • Presentations
    • Stock
      • Stock Quote & Chart
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Committee Composition
    • Financial Information
      • SEC Filings
    • Shareholder Services
      • Investor FAQs
      • Email Alerts
      • Contact Us
About
Team
Science
Join Us
Investor
News
Back
Team
  • Leadership
  • Board
  • Advisors
  • Investors
Back
News
  • Press Releases
  • In The News
Back
Investor
  • Overview
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Stock
    • Stock Quote & Chart
  • Corporate Governance
    • Documents & Charters
    • Committee Composition
  • Financial Information
    • SEC Filings
  • Shareholder Services
    • Investor FAQs
    • Email Alerts
    • Contact Us

SEC Filing Details

Document Details

Form
EFFECT
Filing Date
Oct 10, 2024
Document Date
Oct 10, 2024
Form Description
EFFECT
Filing Group
Other
Company
Upstream Bio
Issuer
UPSTREAM BIO, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Go to Upstream Bio homepage Upstream Bio, Targeting Inflammation at Its Source for Better Health

For inquires, email us at
info@upstreambio.com

890 Winter Street
Suite 200
Waltham, MA 02451

  • About
  • Team
  • Science
  • Join Us
  • News
  • Privacy Policy
  • Terms of Use
Follow Us:
  • LinkedIn
  • Twitter